SFG
ABBV icon

StrategIQ Financial Group’s AbbVie ABBV Stock Holding History

StrategIQ Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$10.2M Sell
66,065
-1,271
-2% -$185K 1.16% 27
2023
Q3 		$10M Buy
67,336
+49
+0.1% +$7.19K 1.16% 26
2023
Q2 		$9.07M Buy
67,287
+83
+0.1% +$12.2K 1.03% 29
2023
Q1 		$10.7M Sell
67,204
-56
-0.1% -$8.56K 1.24% 21
2022
Q4 		$10.9M Sell
67,260
-869
-1% -$133K 1.26% 19
2022
Q3 		$9.14M Sell
68,129
-19,120
-22% -$2.74M 1.16% 20
2022
Q2 		$13.4M Sell
87,249
-7,825
-8% -$1.2M 1.62% 12
2022
Q1 		$15.4M Sell
95,074
-477
-0.5% -$69.3K 1.67% 11
2021
Q4 		$12.9M Buy
95,551
+9,121
+11% +$1.08M 1.3% 17
2021
Q3 		$9.32M Sell
86,430
-10,479
-11% -$1.2M 1.85% 14
2021
Q2 		$10.9M Buy
96,909
+23,252
+32% +$2.62M 2.16% 11
2021
Q1 		$7.97M Sell
73,657
-7,646
-9% -$818K 1.68% 15
2020
Q4 		$8.71M Sell
81,303
-24,271
-23% -$2.33M 1.95% 12
2020
Q3 		$9.25M Buy
105,574
+26
+0% +$2.45K 2.32% 12
2020
Q2 		$10.4M Buy
105,548
+28
+0% +$2.46K 2.79% 6
2020
Q1 		$8.04M Sell
105,520
-157
-0.1% -$13.4K 2.49% 9
2019
Q4 		$9.36M Sell
105,677
-2,151
-2% -$179K 2.41% 9
2019
Q3 		$8.16M Sell
107,828
-1,870
-2% -$128K 2.3% 9
2019
Q2 		$7.98M Buy
109,698
+1,464
+1% +$115K 2.31% 10
2019
Q1 		$8.72M Sell
108,234
-444
-0.4% -$36.3K 2.68% 7
2018
Q4 		$10M Sell
108,678
-1,212
-1% -$107K 3.43% 5
2018
Q3 		$10.4M Buy
109,890
+86
+0.1% +$8.15K 3.29% 5
2018
Q2 		$10.2M Buy
+109,804
New +$10.7M 3.52% 5
2017
Q4 		– Sell
-2,563
Closed -$228K – 160
2017
Q3 		$228K Buy
+2,563
New +$195K 0.09% 139

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

StrategIQ Financial Group's ABBV Position: Q4 2023 in Review

StrategIQ Financial Group reduced its AbbVie (ABBV) stake by 1.9% in Q4 2023, selling an estimated $185K and leaving 66,065 shares worth $10.2M. The position accounts for 1.16% of the portfolio, ranked #27.

StrategIQ Financial Group first reported a position in ABBV in Q3 2017 and has held it in 24 quarters since. The position peaked at $15.4M in Q1 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • StrategIQ Financial Group held 66,065 shares of AbbVie worth $10.2M as of Q4 2023.
  • StrategIQ Financial Group sold 1,271 AbbVie shares in Q4 2023, an estimated $185K.
  • AbbVie made up 1.16% of StrategIQ Financial Group's portfolio in Q4 2023, its #27 holding.
  • StrategIQ Financial Group first reported a position in AbbVie in Q3 2017 and has held it in 24 quarters since.
  • StrategIQ Financial Group's AbbVie position peaked at $15.4M in Q1 2022.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on StrategIQ Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.